Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies

Nester, C; Appel, GB; Bomback, AS; Bouman, KP; Cook, HT; Daina, E; Dixon, BP; Rice, K; Najafian, N; Hui, JM; Podosh, SD; Langman, CB; Lightstone, L; Parikh, SV; Pickering, MC; Sperati, CJ; Trachtman, H; Tumlin, J; de Vries, APJ; Wetzels, JFM; Remuzzi, G

Nester, C (通讯作者)，Univ Iowa, Stead Family Childrens Hosp, Div Nephrol, Iowa City, IA 52242 USA.

AMERICAN JOURNAL OF NEPHROLOGY, 2023; 53 (10): 687

Abstract

Introduction: C3 glomerulopathy (C3G) is an ultrarare, chronic and progressive nephropathy mediated by dysregulation of the alternative pathway of com......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索